Nova Wealth Management, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Nova Wealth Management, Inc.
- $136 Billion
- Q2 2025
A detailed history of Nova Wealth Management, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Nova Wealth Management, Inc. holds 8 shares of ALNY stock, worth $2,593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8
Previous 17
52.94%
Holding current value
$2,593
Previous $4.59 Million
42.18%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
722Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.43 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.23 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$3.09 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.32 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.43 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $39.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...